Halozyme Therapeutics | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amarin USD 112.64M 11.05M 2024-09
Amgen USD 6.78B 535M 2024-12
Baxter International USD 1.73B 53M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
DBV Technologies USD 20.1M 553K 2024-09
Eli Lilly USD 13.28B 1.22B 2024-12
Halozyme Therapeutics USD 308.46M 22.71M 2024-12
Indivior 271M 10M 2024-09
Intra Cellular Therapies USD 166.5M 20.89M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
MannKind USD 37.1M 18.92M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
United Therapeutics USD 279.3M 62.5M 2024-12



Halozyme Therapeutics Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.